ARPA-H Awards BioCurie Grant to Build Scalable Gene Therapy Manufacturing Platform

BioCurie has received a grant from ARPA-H (Advanced Research Projects Agency for Health) to design, build, and validate an AI-powered scalable gene therapy manufacturing platform, the company announced.

The project aims to address one of the biggest bottlenecks in gene therapy development: manufacturing at scale. Current gene therapy production is expensive and limited by manufacturing capacity.

The AI-powered platform will help optimize production processes and reduce costs, potentially making gene therapies more accessible to patients.

ARPA-H is a federal agency created to drive transformative health research breakthroughs. The agency has been funding projects to accelerate development of novel therapies.

Gene therapies have shown remarkable results for certain genetic diseases but remain out of reach for many patients due to high costs and limited manufacturing capacity.